| Authors: |
Sánchez-Lanzas R; Centre for Haemato-Oncology - Barts Cancer Institute, Queen Mary University of London, London, UK., Jiménez-Pompa A; Centre for Haemato-Oncology - Barts Cancer Institute, Queen Mary University of London, London, UK., Smith E; Center for Cancer Genomics and Computational Biology - Barts Cancer Institute, Queen Mary University of London, London, UK., Sumaria N; Centre for Immunobiology - Blizzard Institute, Queen Mary University of London, London, UK., Barclay J; Centre for Haemato-Oncology - Barts Cancer Institute, Queen Mary University of London, London, UK., Kalampalika F; Centre for Haemato-Oncology - Barts Cancer Institute, Queen Mary University of London, London, UK., Pennington DJ; Centre for Immunobiology - Blizzard Institute, Queen Mary University of London, London, UK., Efremova M; Center for Cancer Genomics and Computational Biology - Barts Cancer Institute, Queen Mary University of London, London, UK. m.efremova@qmul.ac.uk., Ganuza M; Centre for Haemato-Oncology - Barts Cancer Institute, Queen Mary University of London, London, UK. m.ganuza@qmul.ac.uk. |
